Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LYKA LABS Fact Sheet  (LYLB)



Must See: Do You Invest in Midcap Stocks? Here's a Great News for You


Here is the latest financial fact sheet of LYKA LABS. For more details, see the LYKA LABS quarterly results and LYKA LABS share price. For a sector overview, read our pharmaceuticals sector report.

LYKA LABS Price History

Price Rs 125.5
Mkt Cap Rs m 4,151
Vol '000 7.2
P/E X -117.7
P/CF X 417.2
EPS (TTM) Rs -1.1
1 Day % 2.4
No. of shares m 33.09
1 Week % 0.1
1 Month % 14.1
1 Year % 10.9
52 week H/L Rs 143.5/89.0
As on Apr 16, 2024 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

LYKA LABS Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
LYKA LABS EQUITY SHARE DATA
High Rs523536267202 
Low Rs21101325100 
Sales per share (Unadj.) Rs25.221.430.167.630.3 
Earnings per share (Unadj.) Rs-2.3-21.8-3.513.4-4.3 
Diluted earnings per shareRs-1.9-18.9-3.011.6-4.0 
Cash flow per share (Unadj.) Rs0.3-19.0-0.619.40.3 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs15.0-5.0-9.04.69.1 
Adj. book value per shareRs12.8-4.3-7.84.08.5 
Shares outstanding (eoy) m28.1428.6928.6928.6930.69 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x1.51.00.82.25.0 
Avg P/E ratio x-16.3-1.0-6.910.9-35.2 
P/CF ratio (eoy) x107.4-1.2-39.37.5465.7 
Price / Book Value ratio x2.4-4.5-2.731.416.5 
Dividend payout %00000 
Avg Mkt Cap Rs m1,0336456944,1894,634 
No. of employees `000NANANANANA 
Total wages/salary Rs m147139146181186 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
LYKA LABS INCOME DATA
Net Sales Rs m7086158631,941931 
Other income Rs m2131162134 
Total revenues Rs m7296468781,962965 
Gross profit Rs m-30-36918694694 
Depreciation Rs m738083173141 
Interest Rs m72201259201119 
Profit before tax Rs m-154-619-141592-132 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-917-412080 
Profit after tax Rs m-64-626-101384-132 
Gross profit margin %-4.3-60.021.548.810.1 
Effective tax rate %58.8-1.228.735.10.1 
Net profit margin %-9.0-101.8-11.719.8-14.1 
LYKA LABS BALANCE SHEET DATA
Current assets Rs m351359291522442 
Current liabilities Rs m848663499994326 
Net working cap to sales %-70.2-49.5-24.1-24.312.5 
Current ratio x0.40.50.60.51.4 
Inventory Days Days149116874190 
Debtors Days Days754477367347789 
Net fixed assets Rs m1,6771,5201,4461,3341,073 
Share capital Rs m281287287287307 
"Free" reserves Rs m141-430-545-154-27 
Net worth Rs m423-143-258133280 
Long term debt Rs m7931,2611,514625638 
Total assets Rs m2,0291,8791,7371,8561,515 
Interest coverage x-1.2-2.10.53.9-0.1 
Debt to equity ratio x1.9-8.8-5.94.72.3 
Sales to assets ratio x0.30.30.51.00.6 
Return on assets %0.4-22.69.131.6-0.8 
Return on equity %-15.0436.539.1288.2-47.0 
Return on capital %-6.8-37.49.4104.7-1.4 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
LYKA LABS CASH FLOW
From Operations Rs m 267 53 88 792 90 
From Investments Rs m -40 -1 -2 -62 74 
From Financial Activity Rs m -234 34 -118 -632 -216 
Net Cashflow Rs m -7 86 -31 99 -53 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 54.8%
Institution 1.0%
Non-Institution 44.2%
Total 100.0%
Free Float 45.2%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2024
 

Company Information

Regd Off 4801/B & 4802/A, G I D C Industrial Estate, Ankleshwar - 393002
E-mail companysecretary@lykalabs.com Web www.lykalabs.com
Tel 02646221422 /220549 Fax 02646-250692
Sector PHARMACEUTICALS Group Private sector
Tr Agent Link Intime India Pvt Ltd., C 101 247 Park, L B S Marg, Vikhroli (West)
Auditor C. C. Chokshi & Co.
CHM: Babulal Jain COMP SEC: Kishore P Shah YEAR OF INC: 1976 BSE CODE: 500259 FV (Rs): 10 DIV YIELD (%): -

Read: LYKA LABS 2022-23 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    

Compare LYKA LABS With:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    



 

Today's Market

Cipla Buys Ivia Beauty Brands | India's Green Power Push | Top Buzzing Stocks Today Cipla Buys Ivia Beauty Brands | India's Green Power Push | Top Buzzing Stocks Today(Pre-Open)

Indian share markets Slipped further as the session progressed and ended the day weak.